672 related articles for article (PubMed ID: 11543655)
1. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
[TBL] [Abstract][Full Text] [Related]
2. Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments.
Burioni R; Plaisant P; Manzin A; Rosa D; Delli Carri V; Bugli F; Solforosi L; Abrignani S; Varaldo PE; Fadda G; Clementi M
Hepatology; 1998 Sep; 28(3):810-4. PubMed ID: 9731577
[TBL] [Abstract][Full Text] [Related]
3. Human antibodies from phage display libraries: expression of recombinant full length immunoglobulin G specific to the hepatitis C virus E2 glycoprotein.
Bugli F; Graffeo R; Pescatori M; Paroni Sterbini F; Torelli R; Masucci L; Manzara S; Fadda G
New Microbiol; 2009 Oct; 32(4):341-9. PubMed ID: 20128440
[TBL] [Abstract][Full Text] [Related]
4. Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity.
Schofield DJ; Bartosch B; Shimizu YK; Allander T; Alter HJ; Emerson SU; Cosset FL; Purcell RH
Hepatology; 2005 Nov; 42(5):1055-62. PubMed ID: 16250048
[TBL] [Abstract][Full Text] [Related]
5. Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses.
Goncalvez AP; Men R; Wernly C; Purcell RH; Lai CJ
J Virol; 2004 Dec; 78(23):12910-8. PubMed ID: 15542643
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.
Mancini N; Canducci F; Carletti S; Berardinelli E; Serafini G; Grieco A; Perotti M; Malcangi G; Danieli MG; Varaldo PE; Clementi M; Burioni R
J Biol Regul Homeost Agents; 2003; 17(2):183-7. PubMed ID: 14518720
[TBL] [Abstract][Full Text] [Related]
7. Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.
Burioni R; Mancini N; Carletti S; Perotti M; Grieco A; Canducci F; Varaldo PE; Clementi M
Virology; 2004 Oct; 327(2):242-8. PubMed ID: 15351212
[TBL] [Abstract][Full Text] [Related]
8. Fabs specific for 8-oxoguanine: control of DNA binding.
Bespalov IA; Bond JP; Purmal AA; Wallace SS; Melamede RJ
J Mol Biol; 1999 Nov; 293(5):1085-95. PubMed ID: 10547287
[TBL] [Abstract][Full Text] [Related]
9. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library.
Mink MA; Benichou S; Madaule P; Tiollais P; Prince AM; Inchauspe G
Virology; 1994 Apr; 200(1):246-55. PubMed ID: 7510436
[TBL] [Abstract][Full Text] [Related]
10. Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization.
Zucchelli S; Roccasecca R; Meola A; Ercole BB; Tafi R; Dubuisson J; Galfré G; Cortese R; Nicosia A
Hepatology; 2001 Mar; 33(3):692-703. PubMed ID: 11230750
[TBL] [Abstract][Full Text] [Related]
11. [Preparation of human single chain Fv antibody specifically against hepatitis C virus E2 antigen].
Zhong Y; Cheng J; Shi S; Wang G; Xia X; Tian X; Li L; Zhang L; Chen J
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):109-11. PubMed ID: 11983126
[TBL] [Abstract][Full Text] [Related]
12. Internal images: human anti-idiotypic Fab antibodies mimic the IgE epitopes of grass pollen allergen Phl p 5a.
Hantusch B; Knittelfelder R; Wallmann J; Krieger S; Szalai K; Untersmayr E; Vogel M; Stadler BM; Scheiner O; Boltz-Nitulescu G; Jensen-Jarolim E
Mol Immunol; 2006 Jul; 43(14):2180-7. PubMed ID: 16510185
[TBL] [Abstract][Full Text] [Related]
13. Generation of an HFRS patient-derived neutralizing recombinant antibody to Hantaan virus G1 protein and definition of the neutralizing domain.
Liang M; Mahler M; Koch J; Ji Y; Li D; Schmaljohn C; Bautz EK
J Med Virol; 2003 Jan; 69(1):99-107. PubMed ID: 12436484
[TBL] [Abstract][Full Text] [Related]
14. Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein.
Diotti RA; Sautto GA; Solforosi L; Mancini N; Clementi M; Burioni R
New Microbiol; 2012 Oct; 35(4):475-9. PubMed ID: 23109015
[TBL] [Abstract][Full Text] [Related]
15. Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries.
Bugli F; Mancini N; Kang CY; Di Campli C; Grieco A; Manzin A; Gabrielli A; Gasbarrini A; Fadda G; Varaldo PE; Clementi M; Burioni R
J Virol; 2001 Oct; 75(20):9986-90. PubMed ID: 11559832
[TBL] [Abstract][Full Text] [Related]
16. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antibody affinity to Japanese encephalitis virus E protein by phage display.
Hong WW; Yen YH; Wu SC
Biochem Biophys Res Commun; 2007 Apr; 356(1):124-8. PubMed ID: 17350601
[TBL] [Abstract][Full Text] [Related]
18. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
[TBL] [Abstract][Full Text] [Related]
19. Non-germ-line encoded residues are critical for effective antibody recognition of a poorly immunogenic neutralization epitope on glycoprotein B of human cytomegalovirus.
Lantto J; Lindroth Y; Ohlin M
Eur J Immunol; 2002 Jun; 32(6):1659-69. PubMed ID: 12115649
[TBL] [Abstract][Full Text] [Related]
20. Isolation of therapeutic human monoclonal antibodies for varicella-zoster virus and the effect of light chains on the neutralizing activity.
Suzuki K; Akahori Y; Asano Y; Kurosawa Y; Shiraki K
J Med Virol; 2007 Jun; 79(6):852-62. PubMed ID: 17457901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
